PROFUND ADVISORS LLC

Position in RGNX — REGENXBIO Inc.

CIK 1129919 BETHESDA, MD

Position in RGNX

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$276,917

-$43,497 QoQ

Shares Held

33,045

+48.5% QoQ

Ownership

0.064%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PROFUND ADVISORS LLC holds $183,791,137 across 158 Biotechnology names. RGNX ranks #130 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,137	$10,331,595
2	REGN	Regeneron Pharmaceuticals, Inc.	10,332	$7,982,916
3	ALNY	Alnylam Pharmaceuticals, Inc.	14,647	$4,846,252
4	INSM	INSMED Inc	27,937	$4,568,258
5	APLS	Apellis Pharmaceuticals, Inc.	81,190	$3,266,273
6	MDGL	Madrigal Pharmaceuticals, Inc.	4,862	$2,545,111
7	TGTX	Tg Therapeutics, Inc.	76,039	$2,526,015
8	ARWR	Arrowhead Pharmaceuticals, Inc.	39,758	$2,492,826

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$276,917	33,045	+48.5%	Shares	Sole	2026-04-27
2025-12-31	$320,414	22,251	+54.1%	Shares	Sole	2026-02-06
2025-09-30	$139,384	14,444	+11.8%	Shares	Sole	2025-11-06
2025-06-30	$106,081	12,921	-29.2%	Shares	Sole	2025-08-07
2024-12-31	$141,118	18,256	+8.3%	Shares	Sole	2025-02-14
2024-09-30	$176,840	16,858	-18.2%	Shares	Sole	2024-11-14
2024-06-30	$241,101	20,607	-30.1%	Shares	Sole	2024-08-13
2024-03-31	$621,565	29,500	+36.3%	Shares	Sole	2024-05-08
2023-12-31	$388,617	21,650	-9.5%	Shares	Sole	2024-02-14
2023-09-30	$393,838	23,927	-20.7%	Shares	Sole	2023-11-13
2023-06-30	$603,118	30,171	+17.3%	Shares	Sole	2023-08-10
2023-03-31	$486,346	25,719	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.